Vault-13

Nextech Invest Ltd.

Zurich, V8 · CIK 1911010 · 13F filing filed 2024-08-14

Exempt reporting adviser since 2022 · other (specify)

As an employer

$594.5m reported value -5.8% vs Q1 2024
13positions
94.0%in top 10
1 new 1 added 0 reduced 0 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 REVOLUTION MEDICINES INC COM RVMD RVMD 6,296,740 $244.4m41.11% 41.11% UnchangedShares held: Q3 2023 4.8m, Q4 2023 6.3m, Q1 2024 6.3m, Q2 2024 6.3m
2 TYRA BIOSCIENCES INC COM TYRA TYRA 4,055,861 $64.9m10.91% 10.91% UnchangedShares held: Q3 2023 2.5m, Q4 2023 2.5m, Q1 2024 4.1m, Q2 2024 4.1m
3 TANGO THERAPEUTICS INC COM TNGX TNGX 5,533,980 $47.5m7.99% 7.99% UnchangedShares held: Q3 2023 5.5m, Q4 2023 5.5m, Q1 2024 5.5m, Q2 2024 5.5m
4 CARGO THERAPEUTICS INC COM COM 2,642,502 $43.4m7.30% 7.30% UnchangedShares held: Q3 2023 0, Q4 2023 2.6m, Q1 2024 2.6m, Q2 2024 2.6m
5 ARVINAS INC COM ARVN ARVN 1,408,394 $37.5m6.31% 6.31% UnchangedShares held: Q3 2023 287.3k, Q4 2023 1.7m, Q1 2024 1.4m, Q2 2024 1.4m
6 ORIC PHARMACEUTICALS INC COM ORIC ORIC 5,285,714 $37.4m6.29% 6.29% UnchangedShares held: Q3 2023 4.3m, Q4 2023 4.3m, Q1 2024 5.3m, Q2 2024 5.3m
7 RELAY THERAPEUTICS INC COM RLAY RLAY 3,846,409 $25.1m4.22% 4.22% UnchangedShares held: Q3 2023 1.2m, Q4 2023 1.3m, Q1 2024 3.8m, Q2 2024 3.8m
8 CULLINAN THERAPEUTICS INC COM CGEM CGEM 1,221,145 $21.3m3.58% 3.58% UnchangedShares held: Q3 2023 1.2m, Q4 2023 1.2m, Q1 2024 1.2m, Q2 2024 1.2m
9 MERSANA THERAPEUTICS INC COM COM 9,526,146 $19.1m3.22% 3.22% AddedShares held: Q3 2023 0, Q4 2023 6.0m, Q1 2024 3.9m, Q2 2024 9.5m +5.7m +5,669,825 147.0%
10 SILENCE THERAPEUTICS PLC ADS SLN SLN 952,400 $18.1m3.04% 3.04% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 952.4k, Q2 2024 952.4k
11 ARS PHARMACEUTICALS INC COM SPRY SPRY 1,910,029 $16.3m2.73% 2.73% UnchangedShares held: Q3 2023 1.9m, Q4 2023 1.9m, Q1 2024 1.9m, Q2 2024 1.9m
12 CONTEXT THERAPEUTICS INC COM CNTX CNTX 7,419,355 $14.9m2.50% 2.50% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 7.4m
13 BOUNDLESS BIO INC COM BOLD BOLD 1,228,069 $4.8m0.80% 0.80% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 1.2m, Q2 2024 1.2m